Completed PHASE4 INTERVENTIONAL 2-arm NCT02443012

Topical Nepafenac as Supplement for Diabetic Macular Edema

Evaluation on Efficacy of Topical Nepafenac as Supplement Therapy in the Treatment of Diabetic Macular Edema

Sponsor: Universiti Sains Malaysia

Interventions Laser Topical Gutt Nepafenac 0.1%

Updated 6 times since 2017 Last updated: May 8, 2015 Started: Mar 31, 2013 Primary completion: Aug 31, 2014 Completion: Aug 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Diabetic Macular Edema, this trial is completed. The trial is conducted by Universiti Sains Malaysia and has accumulated 6 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
May 2020 — Jan 2021 [monthly]

Completed PHASE4
Jun 2018 — May 2020 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Mar 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universiti Sains Malaysia

Data source: Universiti Sains Malaysia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Batu Caves, Malaysia
• Kubang Kerian, Malaysia